Dano, Melitona D.
HRN: 15-69-43 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/23/2024
MUPIROCIN 2%, 15G (TUBE)
02/23/2024
03/01/2024
TOPICAL
Apply Directly
Daily
S/P Parotidectomy, Left
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes